|
About the Merck of Amitriptyline - Elavil
|
|
|
|
|
|
About the manufacturer of
Amitriptyline - Elavil |
Merck & Co., Inc. established in 1891; it the oldest and a global research-driven pharmaceutical company which is working for the discovery, development, manufacturing and marketing of different vaccination and medication which includes Amitriptyline. It has approximately above 61,000 employees, which are devoted to perform extensive research to produce new medicine and further improvement of Amitriptyline more commonly known as Elavil.
Merck has conducted research worldwide in 9 major research centers, and is successfully operating in more than 142 countries and Merck medicine is donated for the people in far flung areas who need medicine. It is also publishing impartial health information to people as non profit service. There are many other pharmaceutical companies which are aligned with Merck is the development of Amitriptyline and all together concentrating on unmet medical needs worldwide.
Merck has major investment in research department which indicate the value of patients, investors and providers and is also working with other companies with internal and external partnerships. In 2006 Merck crossed the sale of $22.8 billion which resulted in the massive investment of $4.9 billion in research and development sector with a majore share coming from Elavil. Merck produce high quality medicines for Alzheimer, diabetes, novel vaccines, obesity and higher interest of focus is oncology, pain and sleep disorders.
Merck is one of major company which is extensively working and focusing on the research of HIV/AIDS, antiviral and fungal and asthma.
In some countries these disease are an epidemic which is the reason of a lot of deaths. Merck and Co, Inc is based in White House Station, New Jersey where Elavil was developed. Merck also produces extensive medical and pharmaceutical reference manuals for professional and home use.
|
|
|
|
|
